kt-333,venetoclax,kt-413
abbvie,kymera therapeutics,roche
['ctcl,(-ctclaboratory)', 'kt-333 ', 'dlbcl', 'venetoclax', 'kt-413', 'kymera ']
our collaborators at and shared preclinical data at #ash2022 on our stat3 and irakimid degraders. learn more about the studies: posters: #biotech #research #collaboration 
Advancing the field of targeted protein degradation to deliver breakthrough medicines for previously untreatable diseases